U Hasholzner
Impact in
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
-
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
Papers in
-
- Ovarian cancer diagnosis and treatment 8
-
- Cancer Research and Treatments 3
- Co-authors
- P StieberA. Fateh‐MoghadamWerner MeierHendrik DienemannHeinz BodenmüllerKarin HofmannDorothea NagelL. Sunder-Plassmann
- Journals
- Cancer (1 paper)Clinical Chemistry and Laboratory Medicine (CCLM) (1 paper)Clinical Nephrology (1 paper)Gynecologic Oncology (1 paper)Clinical Biochemistry (1 paper)
- Partner nations
- GermanyNetherlandsAustria
In The Last Decade
U Hasholzner
22 papers receiving 482 citations
Peers
Comparison fields: 5 of 64
- Reproductive Medicine 80
- Oncology 182
- Pulmonary and Respiratory Medicine 113
- Cell Biology 54
- Epidemiology 113
Countries citing papers authored by U Hasholzner
This map shows the geographic impact of U Hasholzner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U Hasholzner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U Hasholzner more than expected).
Fields of papers citing papers by U Hasholzner
This network shows the impact of papers produced by U Hasholzner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U Hasholzner. The network helps show where U Hasholzner may publish in the future.
Co-authors
The 25 scholars most cited alongside U Hasholzner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 1 | |
| 2 | Serum levels of CA 125 and TPS during treatment of ovarian cancer. | 2001 | 3 |
| 3 | 2000 | 45 | |
| 4 | Nuclear mitotic apparatus protein (NuMA) in benign and malignant diseases. | 1999 | 4 |
| 5 | BTA-TRAK--a useful diagnostic tool in urinary bladder cancer? | 1999 | 30 |
| 6 | CA 242 in comparison with established tumour markers in colorectal, pancreatic and lung cancer. | 1999 | 4 |
| 7 | Value of HAMA--determination in clinical practice--an overview. | 1997 | 12 |
| 8 | CA125 based diagnosis and therapy in recurrent ovarian cancer. | 1997 | 16 |
| 9 | Prognostic significance of CA125 in patients with ovarian cancer and secondary debulking surgery. | 1997 | 7 |
| 10 | Clinical relevance of CYFRA 21-1, TPA-IRMA and TPA-LIA-mat in urinary bladder cancer. | 1997 | 25 |
| 11 | Prognostic significance of squamous cell carcinoma (SCC) antigen in primary advanced and recurrent cervical carcinoma. | 1997 | 3 |
| 12 | Significance of tumor marker determinations in the primary therapy of ovarian cancer. | 1997 | 5 |
| 13 | 1996 | 22 | |
| 14 | Methodological and clinical evaluation of two automated enzymatic immunoassays as compared with a radioimmunoassay for neuron-specific enolase. | 1996 | 10 |
| 15 | 1995 | 2 | |
| 16 | Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma. | 1995 | 30 |
| 17 | 1994 | 39 | |
| 18 | 1993 | 33 | |
| 19 | 1993 | 42 | |
| 20 | 1993 | 169 |
About U Hasholzner
U Hasholzner is a scholar working on Reproductive Medicine, Biotechnology, Radiology, Nuclear Medicine and Imaging, Oncology and Epidemiology, having authored 22 papers that have together received 511 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (8 papers), Neuroendocrine Tumor Research Advances (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Glycosylation and Glycoproteins Research (4 papers), Cancer Research and Treatments (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Reproductive Medicine (80 citations), Oncology (182 citations), Pulmonary and Respiratory Medicine (113 citations), Cell Biology (54 citations) and Epidemiology (113 citations). U Hasholzner has collaborated with scholars based in Germany, Netherlands and Austria. Frequent co-authors include P Stieber, A. Fateh‐Moghadam, Werner Meier, Hendrik Dienemann, Heinz Bodenmüller, Karin Hofmann, Dorothea Nagel, L. Sunder-Plassmann, A. Fateh-Moghadam and N. Schmeller. Their work appears in journals such as Cancer, Clinical Chemistry and Laboratory Medicine (CCLM), Clinical Nephrology, Gynecologic Oncology and Clinical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.